| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/18/2009 | CN101367810A Novel carbpenem antibiotic |
| 02/18/2009 | CN101367809A Penem derivant containing sulfhydryl pyrrolidine formhydrazide |
| 02/18/2009 | CN101367808A Carbpenem compound with heterocycle formyl substituted sulfhydryl pyrrolidine |
| 02/18/2009 | CN101367807A Sulfhydryl pyrrolidine formamido pyridine substituted penem derivant |
| 02/18/2009 | CN101367806A Formyl aniline substituted sulfhydryl pyrrolidine carbpenem compounds |
| 02/18/2009 | CN101367805A Formyl guanidino substituted sulfhydryl pyrrolidine carbpenem compounds |
| 02/18/2009 | CN101367804A Penem derivant containing adamantane |
| 02/18/2009 | CN101367800A Synthesis of tubercle bacillus resistant medicament 3-alkoxyl-8-alkyl -12-R3-jatrorrhizine salt and uses thereof |
| 02/18/2009 | CN101367750A (1S,2S,3S,4R)-3-[(1S)-1-acet-ammonia-2-ethyl-butyl]-4- guanidino-2-hydroxyl-cyclopentyl-1-carboxylic acid aqua compound and medical uses thereof |
| 02/18/2009 | CN101366945A Formulation method for adsorption diphtheria vaccine not containing methanal and thimerosal |
| 02/18/2009 | CN101366897A Chinese medicine capsule for treating hepatitis B |
| 02/18/2009 | CN101366894A Erysipelas treating prescription |
| 02/18/2009 | CN101366881A Traditional Chinese medicine for treating acute infectious conjunctivitis |
| 02/18/2009 | CN101366859A Medicament for treating tinea manus and pedis, fester foot |
| 02/18/2009 | CN101366857A Baicaoyiqiang Chinese medicinal composition and preparation method thereof |
| 02/18/2009 | CN101366853A Chinese medicinal composition for treating athlete's foot |
| 02/18/2009 | CN101366852A Chinese medicinal herb for treating riemerella anatipestifer disease and preparation method thereof |
| 02/18/2009 | CN101366825A Medicament for treating ringworm of the nails |
| 02/18/2009 | CN101366790A Propolis oral liquid and uses thereof |
| 02/18/2009 | CN101366732A Preparation of full-natural centipede dry powder |
| 02/18/2009 | CN101366726A Medicament composition for treating skin diseases |
| 02/18/2009 | CN101366719A Triterpenes anti-AIDS drugs |
| 02/18/2009 | CN101366718A Uses of 7-hydroxide radical-star shaped spore native in preparing medicament for treating virus hepatitis |
| 02/18/2009 | CN101366717A Medicament formulation for treating condyloma acuminata |
| 02/18/2009 | CN101366715A Rapamycin composition and preparation thereof |
| 02/18/2009 | CN101366713A Pharmaceutic use of dandelion xylogen restraint gram-positive bacteria |
| 02/18/2009 | CN101366702A Orally taken or buccal antiviral medicament-Ribavirin tablet and method of preparing the same |
| 02/18/2009 | CN101366510A Infusion beverage for preventing common cold |
| 02/18/2009 | CN100462438C Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus |
| 02/18/2009 | CN100462367C Amidated horseshoe crab anti-endotoxin factor circular analogue peptide molecule, its synthetic method and use |
| 02/18/2009 | CN100462366C Amidated horseshoe crab anti endotoxin factor linear analogue peptide molecule, its synthetic method and use |
| 02/18/2009 | CN100462357C Preparing method of 8-bromo-5,6-difluoro-2-methylquinoline |
| 02/18/2009 | CN100462352C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/18/2009 | CN100462103C Cholesterol phosphononucleoside analogue |
| 02/18/2009 | CN100462102C Mucosal meningococcal multivalence combined vaccines |
| 02/18/2009 | CN100462096C Medicine for enhancing human body immune function and treating Aids and its preparation method |
| 02/18/2009 | CN100462089C Yukangsan herb medicine powder for treating fish diseases |
| 02/18/2009 | CN100462075C Nanometer miconazole nitrate emulsion medicine and its preparation process |
| 02/17/2009 | US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 02/17/2009 | US7491819 N-[4-Fluorophenyl)methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor |
| 02/17/2009 | US7491746 Treating cell proliferation disorder, anticancer agents |
| 02/17/2009 | US7491745 e.g. 2-Ethyl-11-((3-methoxy-5-(1H-pyrrol-2-yl)-2H-pyrrol-2-ylidene)methyl)-10-azabicyclo[7.2.1]dodeca-9(12),11-diene; anticarcinogenic agent; antiproliferative agent, viricide; |
| 02/17/2009 | US7491706 Containing a single-stranded oligonucleotide DNA molecule containing one or more CpG(s); SARS virus, hepatitis C virus, dengue virus and Japanese encephalitis, influenza virus |
| 02/17/2009 | US7491410 Food grade transglutaminase inhibitor and uses thereof |
| 02/17/2009 | US7491406 Fast dissolving orally consumable films |
| 02/17/2009 | US7491401 Lawsonia intracellularis vaccine |
| 02/17/2009 | US7491386 lactic bacteria strain dairy in origin, may administer in an edible composition, adheres to tooth surface and produces growth inhibition factor |
| 02/17/2009 | US7491047 Delivery of antihistamines through an inhalation route |
| 02/17/2009 | CA2428315C Indole and dihydroindole derivatives |
| 02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/17/2009 | CA2371925C Antibacterial compositions |
| 02/17/2009 | CA2355283C Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 02/17/2009 | CA2334267C Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c |
| 02/17/2009 | CA2317691C Triazole derivatives having antifungal activity |
| 02/17/2009 | CA2316411C Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 02/17/2009 | CA2233166C Hormone immunomodulated induction of mucosal immune responses |
| 02/17/2009 | CA1341591C Detoxification of pertussis toxin |
| 02/15/2009 | CA2638448A1 Methods for preventing and treating tissue injury and sepsis associated with yersinia pestis infection |
| 02/12/2009 | WO2009021121A2 Identification and characterization of hcv replicon variants with reduced susceptibility to a combination of polymerase and protease inhibitors, and methods related thereto |
| 02/12/2009 | WO2009020828A1 Crystalline form of methyl ((1s)-1-(((2s)-2-(5-(4'-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-imidazol-5-yl)-4-biphenylyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt |
| 02/12/2009 | WO2009020616A1 Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections |
| 02/12/2009 | WO2009020198A1 Aniline derivative having anti-dna virus activity |
| 02/12/2009 | WO2009019868A1 10a-azalide compound crosslinked at position-10a and position-12 |
| 02/12/2009 | WO2009019661A1 Process for preparation of amorphous lopinavir |
| 02/12/2009 | WO2009019571A2 Method of dissolving essential oils in water |
| 02/12/2009 | WO2009019553A2 Imidazopyridinones |
| 02/12/2009 | WO2009019014A1 Novel benzimidazol-2-yl-alkylamines and the use thereof as microbicidal agents |
| 02/12/2009 | WO2009018780A1 Andrographolide derivatives and use thereof in manufacture of medicaments |
| 02/12/2009 | WO2009018723A1 Sulfonyl-substituted carbapenem compounds |
| 02/12/2009 | WO2009018657A1 Viral polymerase inhibitors |
| 02/12/2009 | WO2009018656A1 Viral polymerase inhibitors |
| 02/12/2009 | WO2009018609A1 Hepatitis c antiviral compositions and methods |
| 02/12/2009 | WO2009002652A9 Use of surfactants for treating mycobacterial infections |
| 02/12/2009 | WO2008129148A3 Use of lactobacillus casei for increasing the protection provided by the influenza vaccine |
| 02/12/2009 | WO2008098985A3 Pharmaceutical composition for the treatment of il-8 mediated diseases |
| 02/12/2009 | WO2008092928A3 NOVEL ß-LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF |
| 02/12/2009 | WO2008079355A3 Method and system for enhancing self-treatment of onychomycosis |
| 02/12/2009 | WO2008004058A3 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 02/12/2009 | WO2007091037A3 Metal-containing virucidal compositions and uses |
| 02/12/2009 | US20090043280 Vaccine Delivery Service |
| 02/12/2009 | US20090043091 Induce immunology response; anticancer agents; 6-(6-Morpholin-4-yl-4-oxo-4H-pyran-2-yl)-thianthrene-2-carboxylate sodium salt; 6-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-thianthrene-2-carboxylic acid methyl ester |
| 02/12/2009 | US20090043076 Modified interferon beta with reduced immunogenicity |
| 02/12/2009 | US20090042973 Inhibitors of aspartyl protease |
| 02/12/2009 | US20090042960 1-Cycloalkyl-5-Iodotetrazoles |
| 02/12/2009 | US20090042953 IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDES |
| 02/12/2009 | US20090042932 Antimicrobial parenteral formulation |
| 02/12/2009 | US20090042927 Salts, Prodrugs and Polymorphs of Fab I Inhibitors |
| 02/12/2009 | US20090042915 Preventive or therapeutic agent for herpesvirus-releated disease |
| 02/12/2009 | US20090042884 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 6-(indol-4-yl)-4-(morpholin-4-yl)-2-[(2-(pyridin-2-yl)ethylamino]pyrimidine |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042860 Compounds for the Treatment of Hepatitis C |
| 02/12/2009 | US20090042858 Lactam containing hcv inhibitors |
| 02/12/2009 | US20090042853 of sulopenem, comprising 2-ethoxy-2-methyl-1-oxopropoxy)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[[(1R,3S)-tetrahydro-1-oxido-3-thienyl]thio]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate, used to treat and prevent bacterial infection in humans; antibiotics |
| 02/12/2009 | US20090042827 Antiviral oligonucleotides targeting hbv |
| 02/12/2009 | US20090042823 Uses of broad spectrum rnai therapeutics against influenza |
| 02/12/2009 | US20090042819 Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use |
| 02/12/2009 | US20090042814 Treatment and Diagnosis of Obligate Intracellular Pathogens |
| 02/12/2009 | US20090042807 By reducing macrophage NO production through administration of one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides; inhibition of neucrosis factor kappa Beta mediated inflammatory cytokine release |
| 02/12/2009 | US20090042801 Method for inhibiting infection and reproduction of influenza type A WSN virus |
| 02/12/2009 | US20090042800 Assay |